Binge drinking in Singapore is less prevalent than internationally, and most binge drinkers engage in the practice only now and then, as reported in a recent study. Despite this trend, binge drinking is associated with a myriad of mental health conditions and reduced quality of life.
Maternal intake of paracetamol during mid-pregnancy was associated with hyperactivity and attention problems in their offspring up to preschool age, although the association was diminished as the children grew older, according to the ALSPAC* study.
The impact of social media use on mental health in teenage girls is primarily due to cyberbullying and disruption in sleep and physical activity, according to an observational study of teenagers in the UK.
Routine use of haloperidol or second-generation antipsychotics to treat delirium in hospitalized adults does not lead to improved patient outcomes, with little evidence of neurologic harms but a tendency for more frequent potentially harmful cardiac effects, a study has shown.
Continuous primary care follow-up during the transition from adolescence to young adulthood could reduce the risk of mental illness-related hospitalizations post-transition in individuals with severe mental illness, according to a Canadian study.
Seven healthcare organizations will collaborate with a pharmaceutical company on building an integrated care ecosystem among private healthcare professionals (HCPs) to manage noncommunicable diseases (NCDs).
In patients with atrial fibrillation (AF) and stable coronary artery disease (CAD), rivaroxaban monotherapy is noninferior to combination treatment with an antiplatelet therapy in terms of cutting the risk of cardiovascular events and mortality, according to data from the AFIRE trial.
Many patients with nonvalvular atrial fibrillation (NVAF) in Thailand use anticoagulants, but the uptake of nonvitamin-K oral anticoagulants remains suboptimal despite showing an upward trend, according to data from the COOL-AF registry presented at the European Society of Cardioloy (ESC) Asia Congress 2019 with APSC and AFC.
Monotherapy with tocilizumab (TCZ) shows good tolerability profile and results in remission in most patients with polymyalgia rheumatica (PMR) despite the absence of glucocorticoids, according to the 2-year results of a single-centre, open‐label pilot study.